当前位置: 首页 > 期刊 > 《中国民族民间医药·下半月》 > 2024年第1期
编号:1843476
中医药治疗膜性肾病足细胞损伤的研究进展
http://www.100md.com 2024年4月14日 中国民族民间医药·下半月 2024年第1期
     黎梅 陈双琴

    【摘 要】 文章分析了膜性肾病与足细胞的关系,简述了单味中药及提取物、中药复方制剂、中西医结合治疗膜性肾病足细胞损伤作用机制及优势,分析表明中西医结合治疗比单纯的中医药治疗有更多的多途径、多靶点及疗效快、副用少等优点,为临床运用中药减少西药副反应或者减少西药的用量和基础实验提供理论依据。

    【关键词】 膜性肾病 ;足细胞损伤 ;单味中药及提取物; 中药复方制剂 ;中西医结合治疗

    【中图分类号】R25? 【文獻标志码】 A? 【文章编号】1007-8517(2024)02-0076-05

    DOI:10.3969/j.issn.1007-8517.2024.02.zgmzmjyyzz202402016

    Research Progress in Treatment of Membranous Nephropathy with Traditional Chinese Medicine

    LI Mei1 CHEN Shuangqin2*

    1.Guangxi University of Traditional Chinese Medicine,Nanning 530000,China;

    2.Department of Renal Medicine,Ruikang Hospital,Guangxi University of Traditional Chinese Medicine,Nanning 530000,China

    Abstract:This article analyzes the relationship between membranous nephropathy and podocytes,and briefly describes the effects and advantages of single traditional Chinese medicine and its extracts,traditional Chinese medicine compound preparations,and integrated traditional Chinese and Western medicine in treating podocyte injury in membranous nephropathy.The analysis shows that integrated traditional Chinese and Western medicine treatment has more advantages such as multiple pathways ......

您现在查看是摘要页,全文长 17866 字符